Pharmocann Global Full Year 2023 Earnings 4.95 loss per share - Simply Wall St
| PHTM Stock | ILA 2,786 2.00 0.07% |
About 54% of Photomyne's investor base is interested to short. The analysis of current outlook of investing in Photomyne suggests that many traders are impartial regarding Photomyne's prospects. The current market sentiment, together with Photomyne's historical and current headlines, can help investors time the market. In addition, many technical investors use Photomyne stock news signals to limit their universe of possible portfolio assets.
Photomyne |
Pharmocann Global Full Year 2023 Earnings 4.95 loss per share Simply Wall St
Read at news.google.com
 |
Photomyne Fundamental Analysis
We analyze Photomyne's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Photomyne using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Photomyne based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Profit Margin
Profit Margin Comparative Analysis
Photomyne is currently under evaluation in profit margin category among its peers. Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Photomyne Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Photomyne stock to make a market-neutral strategy. Peer analysis of Photomyne could also be used in its relative valuation, which is a method of valuing Photomyne by comparing valuation metrics with similar companies.
Peers
Photomyne Related Equities
| MIFT | Millennium Food | 4.33 | ||||
| IDIN | IDI Insurance | 0.91 | ||||
| HRON | Hiron Trade | 1.00 | ||||
| SCOP | Scope Metals | 1.36 | ||||
| CBI | Clal Biotechnology | 2.13 | ||||
| ICB | Israel China | 9.17 |
Complementary Tools for Photomyne Stock analysis
When running Photomyne's price analysis, check to measure Photomyne's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Photomyne is operating at the current time. Most of Photomyne's value examination focuses on studying past and present price action to predict the probability of Photomyne's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Photomyne's price. Additionally, you may evaluate how the addition of Photomyne to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |